Home/Filings/4/0001209191-23-010904
4//SEC Filing

Holtzman Douglas 4

Accession 0001209191-23-010904

CIK 0001786255other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 7:08 PM ET

Size

5.4 KB

Accession

0001209191-23-010904

Insider Transaction Report

Form 4
Period: 2023-02-15
Holtzman Douglas
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+90,00090,000 total
    Exercise: $9.06Exp: 2033-02-14Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.

Issuer

Icosavax, Inc.

CIK 0001786255

Entity typeother

Related Parties

1
  • filerCIK 0001874371

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:08 PM ET
Size
5.4 KB